BARCELONA -- The addition of IV acetazolamide to loop diuretic therapy led to a greater incidence of successful early decongestion in patients with acute decompensated heart failure (HF), according to ...
Drug errors can have severe consequences. Here we describe an inadvertent peribulbar injection of acetazolamide instead of local anaesthetic agent, prior to cataract surgery. A 63-year-old male with ...
Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients with acute decompensated heart failure, according to late breaking research presented in a Hot Line ...
The addition of acetazolamide to loop diuretic therapy improves the success of decongestion in patients with acute decompensated heart failure and volume overload. This finding from the ADVOR trial ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Acetazolamide (Diamox) is prescribed to treat ...
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Acetazolamide for injection 500 mg per single-dose vial, Zydus Cadila said in a filing to ...
For patients with chronic heart failure (HF) who have persistent congestion despite high doses of oral loop diuretics, the right way to intensify diuretics in the outpatient setting may be narrowed, ...
Acetazolamide, a drug that has been commonly used for chronic obstructive pulmonary disease (COPD), does not significantly reduce time on a ventilator for patients with the disease and metabolic ...
Among mechanically ventilated patients with chronic obstructive pulmonary disease (COPD) and metabolic alkalosis, administration of the respiratory stimulant acetazolamide did not significantly reduce ...
The Department of Pharmaceuticals (DoP) has rejected the review application of Sun Pharma Laboratories filed against the retail price fixed by the National Pharmaceutical Pricing Authority’s (NPPA) ...
Among mechanically ventilated patients with chronic obstructive pulmonary disease (COPD) and metabolic alkalosis, administration of the respiratory stimulant acetazolamide did not significantly reduce ...